Exact Mass: 423.1657
Exact Mass Matches: 423.1657
Found 148 metabolites which its exact mass value is equals to given mass value 423.1657
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Neolinustatin
Isolated from flaxseed meal. Neolinustatin is found in many foods, some of which are yardlong bean, european cranberry, hyssop, and macadamia nut. Neolinustatin is found in cereals and cereal products. Neolinustatin is isolated from flaxseed meal.
N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid
coelenterazine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents
Carbidopa; Levodopa
7-Hydroxytrifluoperazine
Coelenterazine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents
[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Trifluoperazine sulfoxide
8-benzyl-6-(4-hydroxy-benzyl)-2-(4-hydroxy-phenyl)-7H-imidazo[1,2-a]pyrazin-3-one|Oplophorus-Luciferin
13-Aethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin|13-ethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine
(9R*,10S*,13R*)-9-hydroxy-3-methoxy-2-methyl-9-(3,4-dimethoxyphenyl)-14-oxa-biciclo[3.2.1]-octa[f]quinolone|helicterone A
3-benzoyl-5-oxo-1-p-tolyl-pyrrolidine-2,2-dicarboxylic acid diethyl ester
Ala Cys Cys Lys
Ala Cys Lys Cys
Ala Gly Asn Tyr
Ala Gly Tyr Asn
Ala Lys Cys Cys
Ala Asn Gly Tyr
Ala Asn Tyr Gly
Ala Tyr Gly Asn
Ala Tyr Asn Gly
Cys Ala Cys Lys
Cys Ala Lys Cys
Cys Cys Ala Lys
Cys Cys Lys Ala
Cys Lys Ala Cys
Cys Lys Cys Ala
Phe Gly Asn Ser
Phe Gly Ser Asn
Phe Asn Gly Ser
Phe Asn Ser Gly
Phe Ser Gly Asn
Phe Ser Asn Gly
Gly Ala Asn Tyr
Gly Ala Tyr Asn
Gly Phe Asn Ser
Gly Phe Ser Asn
Gly Gly Gln Tyr
Gly Gly Tyr Gln
Gly Asn Ala Tyr
Gly Asn Phe Ser
Gly Asn Ser Phe
Gly Asn Tyr Ala
Gly Gln Gly Tyr
Gly Gln Tyr Gly
Gly Ser Phe Asn
Gly Ser Asn Phe
Gly Tyr Ala Asn
Gly Tyr Gly Gln
Gly Tyr Asn Ala
Gly Tyr Gln Gly
Lys Ala Cys Cys
Lys Cys Ala Cys
Lys Cys Cys Ala
Asn Ala Gly Tyr
Asn Ala Tyr Gly
Asn Phe Gly Ser
Asn Phe Ser Gly
Asn Gly Ala Tyr
Asn Gly Phe Ser
Asn Gly Ser Phe
Asn Gly Tyr Ala
Asn Ser Phe Gly
Asn Ser Gly Phe
Asn Tyr Ala Gly
Asn Tyr Gly Ala
Gln Gly Gly Tyr
Gln Gly Tyr Gly
Gln Tyr Gly Gly
Ser Phe Gly Asn
Ser Phe Asn Gly
Ser Gly Phe Asn
Ser Gly Asn Phe
Ser Asn Phe Gly
Ser Asn Gly Phe
Tyr Ala Gly Asn
Tyr Ala Asn Gly
Tyr Gly Ala Asn
Tyr Gly Gly Gln
Tyr Gly Asn Ala
Tyr Gly Gln Gly
Tyr Asn Ala Gly
Tyr Asn Gly Ala
Tyr Gln Gly Gly
Terazosin hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].
AVL-292
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
o-4-methylcoumarinyl-n-[3-(triethoxysilyl)propyl]carbamate
(R)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine
1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)
(2Z)-8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methylidene]-7,8-dihydroimidazo[1,2-a]pyrazin-3-one
3-(5-chloro-2-hydroxyphenyl)-3-phenyl-N-[(4-propan-2-yloxyphenyl)methyl]propanamide
1-[[3-(3,4-Dimethoxyphenyl)-1-phenyl-pyrazol-4-yl]methyleneamino]-3-isopropyl-thiourea
(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2S,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2R,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile
(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2R,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile
3-[4-[(1R,5S)-3-[1,3-benzodioxol-5-yl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
RG-12525
RG-12525 is a a specific, competitive and orally effective antagonist of the peptidoleukotrienes, LTC4, LTD4 and LTE4, inhibiting LTC4-, LTD4- and LTE4-inducd guinea pig parenchymal strips contractions, with IC50s of 2.6 nM, 2.5 nM and 7 nM, respectively; RG-12525 is also a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist with IC50 of appr 60 nM and a potent inhibitor of CYP3A4, with a Ki value of 0.5 μM.
STF-31
STF-31 is a selective inhibitor of glucose transporter 1 (GLUT1), with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. STF-31 inhibits glucose uptake in renal cell carcinoma (RCC) 4 cells[1][2].